Castle Biosciences Inc Cash Flow Quality Index
Castle Biosciences Inc cash flow quality index. Castle Biosciences Inc (CSTL) has a Cash Flow Quality Index of 4.60x as of June 2025. Operating cash flow of $20.82 Million exceeds net income of $4.52 Million, indicating high earnings quality where cash backs reported profits. See CSTL financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Castle Biosciences Inc (2019–2024)
Cash flow quality index of Castle Biosciences Inc from 2019 to 2024. Historical Cash Flow Quality Index for Castle Biosciences Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Castle Biosciences Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Castle Biosciences Inc Cash Flow Quality Index by Year (2019–2024)
Castle Biosciences Inc cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Castle Biosciences Inc. For the full cash flow conversion analysis, see how efficiently does Castle Biosciences Inc generate cash.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.56x | $64.87 Million | $18.25 Million | ▲ +167.4% |
| 2019 | 1.33x | $7.01 Million | $5.28 Million | — |